← Back to headlines
Bernstein Initiates Underperform Rating on Novo Nordisk (NVO)
Bernstein has begun its coverage of Novo Nordisk (NVO) with an "Underperform" rating, indicating a cautious outlook on the pharmaceutical company's stock.
25 Mar, 19:06 — 25 Mar, 19:06
Sources
Showing 1 of 1 sources
